News and Announcements
BNO Licensee, Ironwood Submits IND Application for Anti-Anxiety Drug
- Published November 09, 2012 4:35PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
BIONOMICS LIMITED (BNO) provides the opportunity to listen to an audio broadcast with Dr Deborah Rathjen, CEO and Managing Director discussing BNO Licensee, Ironwood’s submission of an IND Application for Anti-Anxiety Drug IW-2143 (BNC210).
——
To view the full article, please click here.